文献速递产科母胎医学

合并症与妊娠并发症对美国严重孕产妇发病率上升的贡献

Contribution of Comorbidities and Pregnancy Complications to Severe Maternal Morbidity in the United States.
PubMed 文献 · Obstet Gynecol · 2026-02-26

SMM从1.5%升至2.2%,妊娠期高血压疾病(HDP)贡献SMM增幅的32.4%,慢性高血压和肥胖亦有重要贡献。

要点

  • SMM从2016年1.5%升至2022年2.2%,非输血SMM从0.7%升至1.0%。
  • HDP占SMM增幅的32.4%,占非输血SMM增幅的51.3%。
  • 慢性高血压和肥胖对SMM增长有重要贡献,高龄和妊娠期糖尿病贡献较小。

核心结论

  • 美国SMM上升部分归因于慢性高血压、HDP和肥胖负担增加,需针对孕前、孕期及产后心血管代谢健康采取预防干预。

主要发现

  • SMM患病率从1.5%升至2.2%,非输血SMM从0.7%升至1.0%(均P<.001)。
  • HDP患病率从9.8%升至16.6%,慢性高血压从1.4%升至2.6%,肥胖从9.7%升至15.4%。
  • 所有母体风险因素均与SMM更高比值独立相关。
  • 分解分析显示HDP占SMM增幅的32.4%(95%CI 31.2–33.7%),占非输血SMM增幅的51.3%(95%CI 48.5–54.9%)。
  • 慢性高血压和肥胖亦有重要贡献,高龄和妊娠期糖尿病贡献较小。

关键数值与推荐

  • SMM主要结局采用CDC 21项条件算法识别,次要结局排除输血以提高特异性。
  • 趋势检验采用Cochran-Armitage检验,贡献度采用基于参数g计算的分解分析。

临床怎么用

  • 产科医生应重视孕前、孕期及产后慢性高血压、HDP和肥胖的筛查与管理,以降低SMM风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the extent to which rising rates of severe maternal morbidity (SMM) in the United States from 2016 to 2022 are attributable to increasing prevalence of maternal risk factors, including advanced maternal age, obesity, pregestational diabetes mellitus, gestational diabetes, chronic hypertension, and hypertensive disorders of pregnancy (HDP). METHODS: We conducted a retrospective cohort study using the Nationwide Readmissions Database from 2016 to 2022, representing more than 25 million weighted delivery hospitalizations. The primary outcome of SMM was identified with the Centers for Disease Control and Prevention's 21-condition algorithm; a secondary outcome excluded transfusion to improve specificity. Temporal trends in SMM and maternal risk factors were assessed with the Cochran-Armitage test. To quantify the contribution of changes in risk factor prevalence to the overall increase in SMM, we applied a parametric g-computation-based decomposition comparing standardized risks in 2016 and 2022, including counterfactual scenarios in which the distribution of each risk factor was held at 2016 levels. RESULTS: Between 2016 and 2022, the prevalence of SMM increased from 1.5% to 2.2%, and nontransfusion SMM rose from 0.7% to 1.0% (both P <.001). The prevalence of HDP rose from 9.8% to 16.6%, chronic hypertension from 1.4% to 2.6%, and obesity from 9.7% to 15.4%. All maternal risk factors were independently associated with higher odds of SMM. Decomposition analysis showed that HDP accounted for 32.4% (95% CI, 31.2-33.7%) of the increase in SMM and 51.3% (95% CI, 48.5-54.9%) of the increase in nontransfusion SMM. Chronic hypertension and obesity also contributed meaningfully, whereas advanced maternal age and gestational diabetes accounted for a smaller share of the increase. CONCLUSION: The rise in SMM in the United States is partially attributable to the growing burden of chronic hypertension, HDP, and obesity. These findings highlight the urgent need for preventive interventions targeting cardiometabolic health before, during, and after pregnancy.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kawakita T, Jones SA, Furukawa N, et al. Contribution of Comorbidities and Pregnancy Complications to Severe Maternal Morbidity in the United States. Obstet Gynecol. 2026. PMID: 41747267. doi:10.1097/AOG.0000000000006214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。